...
首页> 外文期刊>Macromolecular Research >Fabrication and Controlled Release of Electrosprayed ReoPro-loaded Metal Surface for Vascular Stent
【24h】

Fabrication and Controlled Release of Electrosprayed ReoPro-loaded Metal Surface for Vascular Stent

机译:血管支架电喷涂ReoPro负载金属表面的制备和控制释放

获取原文
获取原文并翻译 | 示例

摘要

Metal stents have been very effective medical devices for coronary artery disease. On the other hand, hyperplasia proliferation of smooth muscle cells and late thrombus formation are the main causes of stent failure. To solve the problem, an anti-platelet/anti-proliferative drug, ReoRro, was used as a target drug for a drug-eluting stent (DES). An emulsion consisting of poly(lactic-co-glycolic acid) (PLGA), ReoRro, and poly(vinyl alcohol) (PVA) was electrosprayed on the stainless steel (SS) specimen. Three specimens were tested: bare-metal SS, PLGA-coated SS, and ReoRro-loaded SS. The surface morphology of polymer/ReoRro layer was smooth and the thickness was approximately 6 μm. When different formulations of emulsion solutions were examined with various amounts of PVA (1, 5, 10%) or ReoRro (10, 20, 30%), the release profiles were affected significantly by the two factors. More PVA content and higher ReoPro concentration could accelerate the drug release in the given time period. Platelet adhesion and smooth muscle cell (SMC) growth were suppressed significantly in the ReoPro-loaded specimens. This indicates that hydrophilic ReoPro release can be controlled in the hydrophobic PLGA-based release system and the released ReoRro can be effective in suppressing platelet adhesion and SMC overgrowth for vascular stents.
机译:金属支架已经成为治疗冠状动脉疾病的非常有效的医疗设备。另一方面,平滑肌细胞增生增生和晚期血栓形成是支架衰竭的主要原因。为了解决该问题,将抗血小板/抗增殖药ReoRro用作药物洗脱支架(DES)的目标药物。将由聚乳酸-乙醇酸共聚物(PLGA),ReoRro和聚乙烯醇(PVA)组成的乳液电喷涂到不锈钢(SS)样品上。测试了三个样本:裸金属SS,PLGA涂层的SS和ReoRro加载的SS。聚合物/ ReoRro层的表面形态光滑,厚度约为6μm。当用各种量的PVA(1、5%,10%)或ReoRro(10%,20%,30%)检查乳液制剂的不同配方时,这两个因素显着影响了释放曲线。在给定的时间内,更多的PVA含量和更高的ReoPro浓度可以加速药物释放。在装有ReoPro的标本中,血小板粘附和平滑肌细胞(SMC)的生长受到显着抑制。这表明可以在基于PLGA的疏水释放系统中控制亲水ReoPro的释放,并且释放的ReoRro可以有效抑制血管支架的血小板粘附和SMC过度生长。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号